OAC
HAE icon

OMERS Administration Corp’s Haemonetics HAE Stock Holding History

OMERS Administration Corp’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,800
Closed -$232K – 971
2024
Q2 		$232K Buy
+2,800
New +$246K ﹤0.01% 858

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

OMERS Administration Corp's HAE Position: Q3 2024 in Review

OMERS Administration Corp sold out of Haemonetics (HAE) in Q3 2024, closing a stake of 2,800 shares — an estimated $232K sold.

OMERS Administration Corp first reported a position in HAE in Q2 2024 and held it in 1 quarter. The position peaked at $232K in Q2 2024. 306 funds tracked by Wall St. Rank hold HAE as of Q3 2024.

  • OMERS Administration Corp reported no remaining Haemonetics position as of Q3 2024 after selling out during the quarter.
  • OMERS Administration Corp sold 2,800 Haemonetics shares in Q3 2024, an estimated $232K.
  • OMERS Administration Corp first reported a position in Haemonetics in Q2 2024 and held it in 1 quarter.
  • OMERS Administration Corp's Haemonetics position peaked at $232K in Q2 2024.
  • 306 funds tracked by Wall St. Rank held Haemonetics as of Q3 2024.

Based on OMERS Administration Corp's 13F filing for Q3 2024, filed 13 Nov 2024.